Treating Urothelial Bladder Cancer

CHF 109.55
Auf Lager
SKU
2BBKQHNGK8Q
Stock 1 Verfügbar
Geliefert zwischen Do., 19.02.2026 und Fr., 20.02.2026

Details

Focuses on the newest aspects of bladder cancer management
Contains examples of clinical cases in each section
Cover most controversal aspects of field

Focuses on the newest aspects of bladder cancer management Features clinical cases in each section Covers many controversial aspects of the field

Autorentext

Paolo Gontero is Associate Professor of Urology at the University of Torino, Italy and currently Chairmen of the Division of Urology, San Giovanni Battista Hospital, Torino, Italy. His main clinical interests are Oncology Urology Surgery, Laparoscopic and Robotic kidney and prostate oncological surgery and Reconstructive Urology. He has authored and co-authored more than 200 publications on international journals.

Francesco Soria is Consultant Urologist at University of Vienna (Urologist, MD, FEBU).

Inhalt
Preface.- Part I: Bladder cancer diagnosis.- Imaging and bladder cancer: can we do better?.- Optical improvements in bladder cancer diagnosis: seeing better for a better management.- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection.- Active surveillance for low risk non-muscle invasive bladder cancer.- Part II: Non-muscle invasive bladder cancer.- How good we are to predict the outcomes of non-muscle invasive bladder cancer?.- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer.- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them?.- Part III: Muscle invasive bladder cancer.- Is there still a role for radical cystectomy?.- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality?.- Neoadjuvant vs adjuvant chemotherapy: which is right?.- Radiotherapy for the treatment of muscle invasive bladder cancer.- Immunotherapy and new combinations.- Part IV: A view on the future.- The role of urologist.- The role of pathologist.- The role of medical oncologist.- The role of radiotherapist.

<p

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09783319785585
    • Editor Paolo Gontero, Francesco Soria
    • Sprache Englisch
    • Auflage 1st edition 2018
    • Größe H260mm x B183mm x T14mm
    • Jahr 2018
    • EAN 9783319785585
    • Format Fester Einband
    • ISBN 3319785583
    • Veröffentlichung 23.08.2018
    • Titel Treating Urothelial Bladder Cancer
    • Gewicht 514g
    • Herausgeber Springer International Publishing
    • Anzahl Seiten 144
    • Lesemotiv Verstehen
    • Genre Medical Books

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38